These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression. Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204 [TBL] [Abstract][Full Text] [Related]
4. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589 [TBL] [Abstract][Full Text] [Related]
5. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice. Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800 [TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 Regulates Atherogenesis by Attenuating Low-Density Lipoprotein Transcytosis and Vascular Inflammation Independently of Endothelial Nitric Oxide Synthase Activation. Ramírez CM; Zhang X; Bandyopadhyay C; Rotllan N; Sugiyama MG; Aryal B; Liu X; He S; Kraehling JR; Ulrich V; Lin CS; Velazquez H; Lasunción MA; Li G; Suárez Y; Tellides G; Swirski FK; Lee WL; Schwartz MA; Sessa WC; Fernández-Hernando C Circulation; 2019 Jul; 140(3):225-239. PubMed ID: 31154825 [TBL] [Abstract][Full Text] [Related]
7. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice. Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843 [TBL] [Abstract][Full Text] [Related]
8. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice. Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693 [TBL] [Abstract][Full Text] [Related]
10. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation. Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009 [TBL] [Abstract][Full Text] [Related]
11. Absence of Four-and-a-Half LIM Domain Protein 2 Decreases Atherosclerosis in ApoE-/- Mice. Ebrahimian T; Simon D; Lemarié CA; Simeone S; Heidari M; Mann KK; Wassmann S; Lehoux S Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1190-7. PubMed ID: 25767273 [TBL] [Abstract][Full Text] [Related]
12. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta. Butcher MJ; Waseem TC; Galkina EV Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405 [TBL] [Abstract][Full Text] [Related]
13. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115 [TBL] [Abstract][Full Text] [Related]
15. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis. Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392 [TBL] [Abstract][Full Text] [Related]
16. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice. Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469 [TBL] [Abstract][Full Text] [Related]
17. Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice. Ji Q; Meng K; Yu K; Huang S; Huang Y; Min X; Zhong Y; Wu B; Liu Y; Nie S; Zhang J; Zhou Y; Zeng Q Sci Rep; 2017 Jun; 7(1):3310. PubMed ID: 28607385 [TBL] [Abstract][Full Text] [Related]
18. P-selectin glycoprotein ligand-1 deficiency leads to cytokine resistance and protection against atherosclerosis in apolipoprotein E deficient mice. Luo W; Wang H; Ohman MK; Guo C; Shi K; Wang J; Eitzman DT Atherosclerosis; 2012 Jan; 220(1):110-7. PubMed ID: 22041028 [TBL] [Abstract][Full Text] [Related]
19. CD27 co-stimulation increases the abundance of regulatory T cells and reduces atherosclerosis in hyperlipidaemic mice. Winkels H; Meiler S; Lievens D; Engel D; Spitz C; Bürger C; Beckers L; Dandl A; Reim S; Ahmadsei M; Hartwig H; Holdt LM; Hristov M; Megens RTA; Schmitt MM; Biessen EA; Borst J; Faussner A; Weber C; Lutgens E; Gerdes N Eur Heart J; 2017 Dec; 38(48):3590-3599. PubMed ID: 29045618 [TBL] [Abstract][Full Text] [Related]
20. A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE-/- mice by reducing lesion necrosis and inflammation. Li Y; Kanellakis P; Hosseini H; Cao A; Deswaerte V; Tipping P; Toh BH; Bobik A; Kyaw T Cardiovasc Res; 2016 Feb; 109(2):305-17. PubMed ID: 26604037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]